BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 12:01:00 PM | Browse: 949 | Download: 1119
Publication Name World Journal of Hepatology
Manuscript ID 13735
Country/Territory Germany
Received
2014-08-29 17:17
Peer-Review Started
2014-08-30 12:11
To Make the First Decision
2014-09-28 12:23
Return for Revision
2014-09-30 18:29
Revised
2014-10-21 00:00
Second Decision
2014-12-11 17:24
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-12-17 16:11
Articles in Press
2014-12-17 16:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-03-20 12:12
Publish the Manuscript Online
2015-03-31 15:58
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Topic Highlights
Article Title Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents
Manuscript Source Invited Manuscript
All Author List Kerstin Herzer and Guido Gerken
Funding Agency and Grant Number
Corresponding Author Kerstin Herzer, MD, Associate Pro­fessor, Department of Gastroenterology and Hepatology, University Hospital Essen, Hufeland str. 55, 45122 Essen, Germany. kerstin.herzer@uk-essen.de
Key Words Hepatitis C virus; Liver transplant; Inter­feron; Sofosbuvir; Simeprevir; Daclatasvir
Core Tip In the liver transplant (LT) setting, graft loss due to hepatitis C virus (HCV) recurrence is a serious problem after LT. The former conventional treatment with pegylated interferon and ribavirin is unsatisfying, due to poor response rates and tolerability. With the first interferon-free regimens that are currently being approved for the treatment of patients with chronic HCV, 2014 marks the beginning of a new era of treatment options for HCV recurrence after LT. This review summarizes the current experience with and the expectations of the new direct-acting antiviral agents in the setting of LT.
Publish Date 2015-03-31 15:58
Citation Herzer K, Gerken G. Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents. World J Hepatol 2015; 7(3): 532-538
URL http://www.wjgnet.com/1948-5182/full/v7/i3/532.htm
DOI http://dx.doi.org/10.4254/wjh.v7.i3.532
Full Article (PDF) WJH-7-532.pdf
Full Article (Word) WJH-7-532.doc
Manuscript File 13735-Review.docx
Answering Reviewers 13735-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 13735-Conflict-of-interest statement.pdf
Copyright License Agreement 13735-Copyright assignment.pdf
Peer-review Report 13735-Peer review(s).pdf
Scientific Misconduct Check 13735-CrossCheck.jpg
Scientific Editor Work List 13735-Scientific editor work list.pdf